4//SEC Filing
PERSEUSPUR LLC 4
Accession 0000950142-10-000407
CIK 0001401923other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 6:55 PM ET
Size
14.8 KB
Accession
0000950142-10-000407
Insider Transaction Report
Form 4
PERSEUSPUR LLC
10% Owner
Transactions
- Sale
Common Stock
2010-03-10$16.04/sh−3,925$62,957→ 2,828,962 total(indirect: See Footnote) - Sale
Common Stock
2010-03-09$15.21/sh−5,000$76,050→ 2,832,887 total(indirect: See Footnote) - Sale
Common Stock
2010-03-08$14.41/sh−5,000$72,050→ 2,837,887 total(indirect: See Footnote)
PEARL FRANK H
10% Owner
Transactions
- Sale
Common Stock
2010-03-10$16.04/sh−3,925$62,957→ 2,828,962 total(indirect: See Footnote) - Sale
Common Stock
2010-03-08$14.41/sh−5,000$72,050→ 2,837,887 total(indirect: See Footnote) - Sale
Common Stock
2010-03-09$15.21/sh−5,000$76,050→ 2,832,887 total(indirect: See Footnote)
Footnotes (7)
- [F1]The price shown in Column 4 is a weighted average sale price. The price range for the sales is $14.25 to $14.59. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F2]All of the securities reported herein are held for the account of Perseus-Soros BioPharmaceutical Fund, LP ("Perseus-Soros"), Perseus-Soros Partners, LLC ("Perseus-Soros Partners"), the general partner of Perseus-Soros, Perseus Biotech Investment, LLC ("PBI"), Perseus Biotech Fund Partners, LLC ("Perseus Biotech Fund Partners"), Biotech Management Partners, LLC ("Biotech Management Partners"), Perseus, L.L.C. ("Perseus"), Perseuspur, L.L.C. ("Perseuspur"), Perseus 2000 Biotech Satellite, LLC ("Perseus Satellite") and Frank H. Pearl. Perseus BioTech Fund Partners is a managing member of Perseus-Soros Partners and Biotech Management Partners. Perseuspur is the managing member of Perseus, PBI, Perseus Biotech Fund Partners and the entity that controls Perseus Satellite. Frank H. Pearl is the managing member of Perseuspur.
- [F3]Represents 5,000 shares of the Issuer's Common Stock sold by Perseuspur. After the sale, Perseuspur owned directly 8,925 shares of the Issuer's Common Stock.
- [F4]The price shown in Column 4 is a weighted average sale price. The price range for the sales is $15.00 to $15.50. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F5]Represents 5,000 shares of the Issuer's Common Stock sold by Perseuspur. After the sale, Perseuspur owned directly 3,925 shares of the Issuer's Common Stock.
- [F6]The price shown in Column 4 is a weighted average sale price. The price range for the sales is $15.90 to $16.13. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F7]Represents 3,925 shares of the Issuer's Common Stock sold by Perseuspur. After the sale, Perseuspur owns directly no shares of the Issuer's Common Stock, Perseus owns directly 2,792 shares of the Issuer's Common Stock, Frank H. Pearl owns directly 1 share of the Issuer's Common Stock and Perseus-Soros owns directly 2,826,169 shares of the Issuer's Common Stock.
Issuer
MAP Pharmaceuticals, Inc.
CIK 0001401923
Entity typeother
Related Parties
1- filerCIK 0001253323
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 6:55 PM ET
- Size
- 14.8 KB